Stock Events

Stock Events

H. Lundbeck AS 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

11NovExpected
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LDB.MU. It's not an investment recommendation.
Novo Nordisk
35
NOVO-B.CO
Amper SA
17
AMP.MC
Microsoft
16
MSFT
Nueva Expresion Textil.
16
NXT.MC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global pharmaceutical company that competes with Lundbeck in the development and marketing of drugs for psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the same therapeutic areas as Lundbeck, including mental health.
Novartis
NVS
Mkt Cap305.1B
Novartis offers products in neurology and psychiatry, directly competing with Lundbeck's portfolio.
Lilly(Eli) &
LLY
Mkt Cap1.08T
Eli Lilly has a strong presence in the psychiatric medication market, making it a direct competitor to Lundbeck.
Merck
MRK
Mkt Cap319.99B
Merck & Co. competes with Lundbeck in the area of brain health, including treatments for neurological conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.34B
Teva Pharmaceutical Industries has a broad portfolio that includes CNS (central nervous system) drugs, competing with Lundbeck.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie, with its neuroscience division, offers products that compete in the same space as Lundbeck's treatments.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol Myers Squibb has a range of psychiatric and neurological drugs, positioning it as a competitor to Lundbeck.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca operates in various therapeutic areas, including those that overlap with Lundbeck's CNS focus.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline has a diversified portfolio that includes medications for mental health, competing with Lundbeck.

About

There is no Profile data available for LDB.MU.
Show more...
CEO
Country
Germany
ISIN
DK0010287234

Listings

MU
DE
LDBA.MU
Grey Market
US
LDBMF
STU
DE
LDBA.STU
MU
DE
LDB.MU

0 Comments

Share your thoughts

FAQ

What is H. Lundbeck AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange H. Lundbeck AS stocks are traded under the ticker LDB.MU.
In which sector is H. Lundbeck AS located?▼
H. Lundbeck AS operates in the Materials sector.
When did H. Lundbeck AS complete a stock split?▼
H. Lundbeck AS has not had any recent stock splits.